Science Explorer Back to mapMap
Discussion
Company · Solna · Sweden

Pharmanest (Sweden)

pharmanest.seROR OpenAlex
Research works
2
fractional, all time
Citations
15
8.9 per fractional work
Top-10% rate
4.6%
all institutions 10.0%
Open access
72%
world 40%
International
80%
world 18%
Pharmanest (Sweden)

Not ranked overall: Pharmanest (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Pharmanest (Sweden) work in?

In all years, 76% of research at Pharmanest (Sweden) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (65%), Biochemistry, Genetics and Molecular Biology (12%), Neuroscience (12%). It does 1.3× the world's share of Health Sciences.

Health Sciences: 1 fractional works · 76.5% of its workMedicine: 1 fractional works · 64.7% of its workNursing: 0 fractional works · 11.8% of its workLife Sciences: 0 fractional works · 23.5% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 11.8% of its workNeuroscience: 0 fractional works · 11.8% of its workALL ITS WORKPharmanest(Sweden)2fractional works, all years
Life Sciences24%Health Sciences76%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 4 fields, with their numbers
    1. Medicine164.7%
    2. Nursing011.8%
    1. Biochemistry, Genetics and Molecular Biology011.8%
    2. Neuroscience011.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Pharmanest (Sweden)?

The most cited paper from Pharmanest (Sweden) is "ILSI/HESI maternal toxicity workshop summary: maternal toxicity and its impact on study design and data interpretation" (Bruce K. Beyer, Neil Chernoff, Bengt R. G. Danielsson et al., 2010), with 68 citations. Next come "Proopiomelanocortin and melanocortin receptors in the adult rat retino-tectal system and their regulation after optic nerve transection" (15) and "In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis" (12).

Most cited papers
#PaperReleasedCitations
1 ILSI/HESI maternal toxicity workshop summary: maternal toxicity and its impact on study design and data interpretation Bruce K. Beyer, Neil Chernoff, Bengt R. G. Danielsson et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology 23 Dec 2010 68
2 Proopiomelanocortin and melanocortin receptors in the adult rat retino-tectal system and their regulation after optic nerve transection Niclas Lindqvist, Ulla Näpänkangas, Jonas Lindblom et al. · European Journal of Pharmacology 21 Nov 2003 15
3 In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis Chittampalli N. Yashaswini, Bruno Cogliati, Tianyue Qin et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 27 Feb 2025 12
4 Mannose Supplementation Curbs Liver Steatosis and Fibrosis in Murine MASH by Inhibiting Fructose Metabolism John G. Hong, Yvette Carbajal, Joshaya C. Trotman et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 17 Jan 2024 4
5 Fibrotic remodeling in the NOD/ShiLtJ mouse model of Sjögren’s disease: insights from single-cell transcriptomics and AI-driven ECM quantification Jennifer M. Morrissey, Deirdre A. Nelson, Li Chen et al. · Frontiers in Immunology Open access 20 Jul 2026 0
All 6 most cited papers, with filters and sorting

Which research topics does Pharmanest (Sweden) publish most on?

By volume in 2022-now: Diet and metabolism studies, Birth, Development, and Health, Liver Disease Diagnosis and Treatment and Liver physiology and pathology.

Diet and metabolism stud…0Diet and metabolism studies: 0 fractional worksBirth, Development, and …0Birth, Development, and Health: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksLiver physiology and pathology: 0 fractional worksDiet, Metabolism, and Disease: 0 fractional works
PhysiologyPediatrics, Perinatology and Child HealthEpidemiologyHepatology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diet and metabolism studies Physiology 0 works
  2. 2 Birth, Development, and Health Pediatrics, Perinatology and Child Health 0 works
  3. 3 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  4. 4 Liver physiology and pathology Hepatology 0 works
  5. 5 Diet, Metabolism, and Disease Endocrinology, Diabetes and Metabolism 0 works
  6. 6 CAR-T cell therapy research Oncology 0 works
  7. 7 Peptidase Inhibition and Analysis Oncology 0 works
  8. 8 AI in cancer detection Artificial Intelligence 0 works
  9. 9 Bariatric Surgery and Outcomes Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available71.6%not open28.4%

World: 40% of research is openly available.

with international co-authors80.2%domestic only19.8%

World: 18% is written across borders.

How has Pharmanest (Sweden)'s research output changed?

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Solna

All research institutions in Solna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Pharmanest (Sweden). Posts are plain text and can be reported.